Filter
1953
Filtered Results: 1953
Text search:
trials
guidelines
Featured
Recommendations
210
New Publications
376
Language
Document type
No document type
1060
Guidelines
375
Studies & Reports
301
Manuals
93
Strategic & Response Plan
44
Fact sheets
35
Training Material
23
Situation Updates
8
Infographics
6
Resource Platforms
5
Brochures
2
Videos
1
Countries / Regions
India
107
Global
81
South Africa
54
Kenya
41
Western and Central Europe
33
Africa
28
Nigeria
23
Ethiopia
23
Uganda
22
Sierra Leone
19
Zambia
19
Nepal
17
Tanzania
17
Malawi
17
Eastern Europe
16
Russia
16
Philippines
15
Brazil
15
Latin America and the Carribbean
15
Liberia
14
Ghana
14
Ukraine
14
Zimbabwe
13
Rwanda
13
Indonesia
13
East and Southern Africa
12
Bangladesh
11
West and Central Africa
11
South–East Asia Region
11
Asia
11
Namibia
10
Congo, Democratic Republic of
8
South Sudan
8
Mozambique
8
Lesotho
7
USA
6
Cameroon
6
Germany
6
Syria
6
Eswatini/ Swaziland
6
Colombia
6
Botswana
6
Guinea
5
Senegal
5
Cambodia
5
Thailand
5
Peru
5
Myanmar / Burma
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Burkina Faso
4
Haiti
4
Argentina
4
Albania
4
United Kingdom
4
Guinea-Bissau
3
Lebanon
3
Sudan
3
Angola
3
Georgia
3
Vietnam
3
North America
3
Spain
3
Morocco
2
Pakistan
2
Iraq
2
China
2
Burundi
2
Mexico
2
Sri Lanka
2
Western Pacific Region
2
Paraguay
2
Venezuela
2
Laos
2
Tajikistan
2
Estonia
2
Iran
2
Kyrgyzstan
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Singapore
1
Benin
1
Central African Republic
1
North Macedonia
1
Hungary
1
Ecuador
1
Greece
1
Madagascar
1
Chile
1
Bulgaria
1
Kazakhstan
1
Jamaica
1
Denmark
1
France
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
500
Clinical Guidelines
322
Public Health
152
Women & Child Health
128
Key Resources
41
Pharmacy & Technologies
27
Capacity Building
23
Toolboxes
Mental Health
243
HIV
222
COVID-19
172
TB
167
NCDs
87
AMR
60
NTDs
59
Caregiver
53
Pharmacy
46
Rapid Response
45
Ebola
36
Planetary Health
32
Disability
25
Conflict
21
Refugee
17
Global Health Education
15
Polio
12
Zika
9
Cholera
7
Natural Hazards
6
Specific Hazards
5
Social Ethics
4
Health Financing Toolbox
4
Diets are changing everywhere, and the burden of disease associated with unhealthy diets is a worldwide concern. Measurement and monitoring of diets across countries and population groups is critical. However, there are no harmonized metrics for tracking how the healthfulness of diets around the wor...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Unfortunately, current data available on SDG financing are not sufficient to quantify the distribution of financing for the SDGs.
AidData’s methodology for measuring financing to the SDGs attempts to fill this gap by analyzing development project documentation to estimate project-level contributi...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents.
The guidance pro...
African countries, like many regions of the world, are affected by the legacy of atrocity crimes. Genocide, the transatlantic slave trade and slavery, colonialism and post-independence violence committed during dictatorships, not to mention civil war and violent extremism, have severely violated hum...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
A major problem facing the world is how to build peace following the ravages of increasingly protracted armed conflict. Armed conflicts leave behind shattered, divided societies that are at risk of repeating cycles of violence, and therefore need concerted peacebuilding efforts. Conflicts also take ...
